6[1]Gori S,Mosconi AM,Basurtol C,et al.Weekly paclitaxel in metastatic breast cancer patients:a phase Ⅱ study[J].Tumori,2002,88 (6):470 -473.
7[2]Sledge GW,Loehrer PJ,Roth BJ,et al.Cisplatin as firstline therapy for metastatic breast cancer.[J].J clin oncol,1988,6(12):1811-1814.
8[4]Miller AB,Hoogtraten MB,Staquet M,et al.Reporting results of cancer treatment[J].Cancer,1981,47 (1):207-214.
9[5]Wilson WH,Berg SL,Bryant G,et al.Paclitaxel in doxorubicin refractory or mitoxantrone-refractory breast cancer:a phase Ⅰ/Ⅱ trial of 96-hour infusion[J].J Clin Oncol,1994,12(8):1621-1629.
10[6]Sweeney CJ,Zhu J,Sandler AB,et al.Outcome of patients with a performance status of 2 in eastern cooperative oncology group study E1594:a phase Ⅱ trial in patients with me tastatic nonsmall cell lung carcinoma[J].Cancer,2001,92(10):2639-2647.
